Volume 3, Number 2;  July 14, 2004

16,000 eJournals!

Grady Branch's Emory Online Resources Page (direct links)

Resident Report Literature - Archival Listings

Evidence-Based Medicine Search Tools and Links

 

 

37-year-old African-American female with pain & redness on right thigh.

 

Recommended reading:

Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus--an emerging problem for the management of skin and soft tissue infections. [Review] [130 refs]

 

(Dr. Antil)

 

<HIPAA Compliance: Patient specifics and lab values have been slightly altered to disguise the identity of this patient>

Case:  37 y.o. AAF comes to the ECC complaining of 1 week history of increased swelling, redness, and pain in her anterior R thigh.  She was seen in the ECC 2 days prior to admission, diagnosed with cellulitis, and given Bactrim DS bid.  She returns to the ECC stating the area is worse and her pills don’t work.  Currently, the patient denies HA, fever, chills, cough, weight loss or gyn symptoms.  The patient has no significant past medical history,  has a 20 pack-year history of cigarette smoking and uses intra-nasal cocaine (last use 2 weeks ago).

            On physical exam she is afebrile with stable vital signs.  On her anterior R thigh she has a 11cm x 5cm area of erythema, induration, warmth, and tenderness, just inferior to the inguinal fold.  The inferior portion of the area is pustular and is incised and drained.

 

Labs:   WBC – 11,600  (seg 73%, lymph 18%, monos 6%, eos 5%)

            Hct – 33.6%

            Plt – 329,000

            HIV negative

            Blood cultures negative x2

            Exudate culture = Staph aureus Susceptibility

PCN: R

Oxacillin: R

Cefazolin: R V

anco: < 0.5 S

TMP-SMX: S

 

Clinical Question(s): 

1) What is the appropriate management of community-acquired MRSA skin infection (CA-MRSA)?

2) Who is at high-risk for CA-MRSA skin infection?

 

Readings:

 

 Link Directly to Fulltext article in Ovid

<26>

Unique Identifier:12734443

Authors: Eady EA. Cove JH.

Institution: School of Biochemistry and Molecular Biology, University of Leeds, UK. j.h.cove@leeds.ac.uk

Title: Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus--an emerging problem for the management of skin and soft tissue infections. [Review] [130 refs]

 

Source: Current Opinion in Infectious Diseases. 16(2):103-24, 2003 Apr.

Abstract: PURPOSE OF REVIEW: In the community non-localized or deep staphylococcal skin and soft tissue infections are typically managed with beta-lactamase stable penicillins. The aims of this review are (1) to evaluate the evidence for the emergence of new strains of community-acquired methicillin resistant Staphylococcus aureus (MRSA), (2) to identify the reasons for their significant association with cutaneous infections, and (3) to consider how they arose and how big a threat they pose to the management of such infections outside hospitals. RECENT FINDINGS: MRSA are emerging as significant community pathogens, especially in previously healthy children with no recognizable risk factors, and are predominantly associated with skin and soft tissue infections (especially abscesses and cellulitis). When present, risk factors are generally similar to those for infection with methicillin susceptible S. aureus. The MRSA isolates associated with such infections may not be entirely 'new', but could represent the displacement of some hospital clones (e.g. EMRSA-15 or variants thereof) to the community as well as the de-novo generation of novel MRSA clones by multiple horizontal transmissions of the mecA gene into methicillin susceptible S. aureus with different genetic backgrounds, some of which are already circulating globally. Community-acquired MRSA from diverse locations are non multiresistant and almost always contain the novel type IV SCCmec commonly found in coagulase-negative staphylococci, but also in hospital-associated gentamicin susceptible MRSA from France, the paediatric clone and in EMRSA-15. SUMMARY: More local data on CA-MRSA infections are needed so that dermatologists and community physicians can assess the risk of such infections amongst their patients and avoid the inappropriate administration of beta-lactams. No simple change in prescribing practices will entirely alleviate selective pressure for the spread of community-acquired MRSA and not exacerbate resistance in pyogenic streptococci, commonly found together with S. aureus in skin and soft tissue infections. The importance of hygiene in preventing the spread of community-acquired MRSA in the community must be reemphasized. [References: 130]

 

 

Resident Report / Department of Medicine & Grady Branch Library

Emory University School of Medicine

2004 Edition

Participating Faculty:  Carlos Del Rio MD  / Joyce Doyle MD / Lorenzo Difrancesco MD /  Monica Adams MD  / Josh Larned MD

Contact: Karl Woodworth 

 AMReport Main Page Library Dept Medicine Other Links